• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

(R)-2-amino-2-cyclobutylacetic acid hydrochloride and Its Significance in Modern Chemical Biology

(R)-2-amino-2-cyclobutylacetic acid hydrochloride, with the CAS number 1958125-89-7, is a compound of significant interest in the field of chemical biology and pharmaceutical research. This chiral amino acid derivative has garnered attention due to its unique structural properties and potential applications in drug development. The hydrochloride salt form enhances its solubility, making it a valuable intermediate in synthetic chemistry and a promising candidate for further biological investigation.

The< strong> (R)-configuration of this compound is particularly noteworthy, as enantiomeric purity is often critical in pharmaceutical applications. The cyclobutyl group introduces steric hindrance, which can influence the compound's interactions with biological targets. This structural feature makes it a fascinating subject for studying enzyme kinetics and binding affinities. Recent advancements in computational chemistry have enabled researchers to predict the binding modes of such compounds with high accuracy, facilitating the design of more effective drugs.

In the realm of drug discovery, (R)-2-amino-2-cyclobutylacetic acid hydrochloride has been explored for its potential role in modulating various biological pathways. Its amino group provides a site for further functionalization, allowing chemists to tailor the molecule for specific therapeutic purposes. For instance, derivatives of this compound have shown promise in inhibiting certain enzymes implicated in inflammatory responses. Such findings align with the growing interest in developing targeted therapies that minimize side effects while maximizing efficacy.

The< strong> hydrochloride salt form of this compound not only improves its pharmacokinetic properties but also enhances its stability during storage and transportation. These attributes are crucial for clinical trials and large-scale pharmaceutical production. Moreover, the cyclobutyl moiety is known to increase metabolic stability, reducing the likelihood of rapid degradation in vivo. This characteristic is particularly valuable for designing long-acting drugs that require fewer dosing intervals.

Recent studies have also highlighted the< strong> synthetic utility of (R)-2-amino-2-cyclobutylacetic acid hydrochloride as a building block for more complex molecules. Researchers have leveraged its scaffold to develop novel analogs with enhanced biological activity. For example, modifications at the amino group have led to compounds with improved binding affinity to specific receptors. Such innovations underscore the importance of chiral amino acids in medicinal chemistry and their potential to revolutionize drug design.

The< strong> role of computational modeling in understanding the behavior of (R)-2-amino-2-cyclobutylacetic acid hydrochloride cannot be overstated. Advanced algorithms allow scientists to simulate molecular interactions at an atomic level, providing insights that would be difficult to obtain through experimental methods alone. These simulations have been instrumental in predicting the efficacy and safety profiles of new drug candidates before they enter clinical trials. This approach not only accelerates the drug development process but also reduces costs associated with traditional trial-and-error methods.

In conclusion, (R)-2-amino-2-cyclobutylacetic acid hydrochloride represents a significant advancement in chemical biology and pharmaceutical research. Its unique structural features, combined with its synthetic versatility, make it a valuable tool for developing novel therapeutics. As research continues to uncover new applications for this compound, its importance in modern medicine is likely to grow even further. The integration of computational techniques with traditional experimental approaches will continue to drive innovation in this field, bringing us closer to more effective and targeted treatments for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)